BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · IEX Real-Time Price · USD
28.01
-0.84 (-2.91%)
At close: May 31, 2024, 4:00 PM
28.00
-0.01 (-0.04%)
After-hours: May 31, 2024, 7:19 PM EDT
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $5.24 billion as of May 31, 2024. Its market cap has increased by 145.72% in one year.
Market Cap
5.24B
Enterprise Value
6.45B
1-Year Change
145.72%
Ranking
Category
Stock Price
$28.01
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.17B to $5.24B, an increase of 65.44%. That is a compound annual growth rate of 10.75%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 5.24B | -2.91% |
May 30, 2024 | 5.40B | 4.49% |
May 29, 2024 | 5.17B | -0.75% |
May 28, 2024 | 5.21B | -0.43% |
May 24, 2024 | 5.23B | 0.65% |
May 23, 2024 | 5.19B | -5.16% |
May 22, 2024 | 5.48B | -0.03% |
May 21, 2024 | 5.48B | -0.81% |
May 20, 2024 | 5.52B | -1.89% |
May 17, 2024 | 5.63B | -3.06% |
May 16, 2024 | 5.81B | 3.57% |
May 15, 2024 | 5.61B | 3.52% |
May 14, 2024 | 5.42B | 1.58% |
May 13, 2024 | 5.33B | -2.06% |
May 10, 2024 | 5.45B | 1.29% |
May 9, 2024 | 5.38B | 3.72% |
May 8, 2024 | 5.18B | -0.32% |
May 7, 2024 | 5.20B | -1.07% |
May 6, 2024 | 5.26B | 0.94% |
May 3, 2024 | 5.21B | 0.32% |
May 2, 2024 | 5.19B | 9.22% |
May 1, 2024 | 4.75B | 5.50% |
Apr 30, 2024 | 4.50B | 0.59% |
Apr 29, 2024 | 4.48B | 2.37% |
Apr 26, 2024 | 4.37B | 2.26% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Stevanato Group | 5.54B |
Organon & Co. | 5.49B |
Ionis Pharmaceuticals | 5.48B |
R1 RCM | 5.42B |
Bausch + Lomb | 5.38B |
Option Care Health | 5.18B |
Doximity | 5.14B |
Madrigal Pharmaceuticals | 5.03B |